Citation: R. Dolhoferbliesener et al., POSSIBLE SIGNIFICANCE OF ADVANCED GLYCATION END-PRODUCTS IN SERUM IN END-STAGE RENAL-DISEASE AND IN LATE COMPLICATIONS OF DIABETES, European journal of clinical chemistry and clinical biochemistry, 34(4), 1996, pp. 355-361
Authors:
DOLHOFERBLIESENER R
LECHNER B
DEPPISCH R
RITZ E
GERBITZ KD
Citation: R. Dolhoferbliesener et al., IMMUNOLOGICAL DETERMINATION OF ADVANCED GLYCOSYLATION END-PRODUCTS INHUMAN BLOOD AND URINE, Nephrology, dialysis, transplantation, 10(5), 1995, pp. 657-664
Citation: R. Dolhoferbliesener et al., IMPAIRED IMMUNOGLOBULIN-G FC FRAGMENT FUNCTION IN DIABETICS IS CAUSEDBY A MECHANISM DIFFERENT FROM GLYCATION, European journal of clinical chemistry and clinical biochemistry, 32(5), 1994, pp. 329-336